Verification evidence is still being completed.
PDF / print export
Cureline Baltic
Vilnius, Lithuania
- Verified lead
- Olga Potapova
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Founder and Chief Executive Officer, Cureline Group
- 2026 technical specialization
- Human Biospecimen CRO, Preclinical Study Design, and Bioanalytical Laboratory Services
- Review cycle
- 24 April 2026
- Full address
- Vilnius, Lithuania (Cureline Baltic operations)
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Invest Lithuania coverage of Cureline establishing a research team in Lithuania under Cureline Group founder and CEO Olga Potapova.
- Editorial note
- Vilnius arm of the global Cureline Group CRO with named founder-CEO, human-biospecimen and preclinical CRO scope, and documented LithuaniaBIO association membership.
Human Biospecimen CRO, Preclinical Study Design, and Bioanalytical Laboratory Services
Cureline Group parent recognition, LithuaniaBIO association member, Invest Lithuania coverage
Vilnius arm of the global Cureline Group CRO with named founder-CEO, human-biospecimen and preclinical CRO scope, and documented LithuaniaBIO association membership.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Vilnius arm of the global Cureline Group CRO with named founder-CEO, human-biospecimen and preclinical CRO scope, and documented LithuaniaBIO association membership.
- Lead
- Olga Potapova (verified ↗)
- Address
- Vilnius, Lithuania (Cureline Baltic operations) (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- CRO service delivery
- Capabilities
- Human Biospecimen Procurement and Biobanking · Preclinical Study Design and Custom Animal Models · Bioanalytical Laboratory Services
- Founded
- 2014
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Olga Potapova
Founder and Chief Executive Officer, Cureline Group
Full addressVilnius, Lithuania (Cureline Baltic operations)
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
CRO service delivery
Vilnius, Lithuania. Human Biospecimen CRO, Preclinical Study Design, and Bioanalytical Laboratory Services. Review completed on 24 Apr 2026.
Lithuanian State Medicines Control Agency and international human-subject frameworks
Cureline Group parent recognition, LithuaniaBIO association member, Invest Lithuania coverage
Human Biospecimen CRO, Preclinical Study Design, and Bioanalytical Laboratory Services
Vilnius arm of the global Cureline Group CRO with named founder-CEO, human-biospecimen and preclinical CRO scope, and documented LithuaniaBIO association membership.
Editorial note
Cureline Baltic is the Lithuanian operating arm of the global Cureline Group (founder and CEO Olga Potapova), established in Vilnius from 2021 with MS and PhD research and medical professionals.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Human Biospecimen Procurement and Biobanking
Preclinical Study Design and Custom Animal Models
Bioanalytical Laboratory Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Human biospecimen processing
Preclinical study operations
Bioanalytical laboratory
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Cureline Baltic located?
- Cureline Baltic operates from Vilnius, Lithuania (Cureline Baltic operations), Vilnius, Lithuania.
- Who runs Cureline Baltic?
- Cureline Baltic is led by Olga Potapova, Founder and Chief Executive Officer, Cureline Group. Verified 24 Apr 2026.
- What does Cureline Baltic do?
- Vilnius arm of the global Cureline Group CRO with named founder-CEO, human-biospecimen and preclinical CRO scope, and documented LithuaniaBIO association membership. Core capabilities: Human Biospecimen Procurement and Biobanking, Preclinical Study Design and Custom Animal Models, Bioanalytical Laboratory Services.
Editorial context
Related technical briefs
Briefs that name Vilnius as a covered market or city.